期刊文献+

胆肠吻合口旁植入氟尿嘧啶缓释剂的药代动力学变化及其意义 被引量:2

暂未订购
导出
摘要 目的探讨胆肠吻合口旁植入氟尿嘧啶缓释剂化疗的药代动力学变化及其意义。方法健康新西兰白兔12只。手术经腹胆肠吻合口旁植入氟尿嘧啶缓释剂。按不同时段取胆肠吻合口,吻合口旁胆管以及吻合口旁肠管组织通过高效液体色谱法检测药物浓度。结果植药点局部组织药物浓度以吻合口植入点为中心随距离增加浓度递减;局部组织药物浓度随着植药时间的延长递减;植药后2周,胆肠吻合口、距植药点1 cm处胆管、肠管组织浓度均大于抑瘤浓度(0.05μg/g)。结论胆肠吻合口旁植入氟尿嘧啶缓释剂化疗能使局部胆肠吻合口、肠管及胆管组织持久维持较高的有效药物浓度,可作为预防和治疗术后胆肠吻合口局部复发和转移的一种有效的辅助化疗手段。
出处 《广东医学》 CAS CSCD 北大核心 2011年第16期2107-2109,共3页 Guangdong Medical Journal
  • 相关文献

参考文献9

  • 1ZERVOS E E, ROSEMURGY A S, AL SAIF O, et al. Surgical management of early - stage pancreatic cancer[ J ]. Cancer Contol, 2004, 11(1): 23.
  • 2倪泉兴,傅德良,蒋永剑,张群华,姚琪远,虞先浚,张延龄.胰头癌淋巴转移特点的探索和影响的因素[J].中华肝胆外科杂志,2004,10(4):231-234. 被引量:20
  • 3GUGLIELMI A, RUZZENENTE A, IACONO C. Surgical treatment of hilarand intrahepatic cholangiocarcinoma [ M ]. Berlin: Springer, 2008 : 3 - 15, 49 -63, 113 - 127, 163 - 168.
  • 4FUNAMI Y, TOKUMOTO N, MIYAUCHI H, et al. Prognostic value of peritoneal lavage cytology and chemotherapy during surgery for advanced gastric cancer[J].Int Surg, 1999, 84(3) : 220 - 224.
  • 5ARCHER S, GRAY B. Intraperitoncal 5 - fluorouracil intusion for treatment of both peritoneal and liver micrometastases [ J ]. Surgery, 1990, 108(3) : 502 -507.
  • 6韩晓燕,卫洪波,连建学,张练,娄朝轩,汪雁明.5-氟尿嘧啶不同给药途径的药代动力学研究和临床应用[J].中国新药杂志,1999,8(1):20-23. 被引量:38
  • 7孟强,孟荣贵,崔龙.直肠癌淋巴结转移状态对淋巴化疗和区域缓释化疗药物聚集浓度的影响[J].消化外科,2006,5(5):308-310. 被引量:18
  • 8BREM H, EWEND M G, PIANTADOSI S, et al. The safety of interstitial chemotherapy with BCNU - loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial[J]. J Neurooncol, 1995, 26(2) : 111 - 123.
  • 9RUEL GARIEPY E, SHIVE M, BICHARA A, et al. A thermosensitive chitosan - based hydrogel for the local delivery of paclitaxel [J]. Eur J Pharm Biopharm, 2004, 57 ( 1 ) : 53 - 63.

二级参考文献14

  • 1陈江浩,杨引明,李开宗,凌瑞,姚青,杨华.乳腺癌淋巴化疗与静脉化疗后腋窝淋巴结药物浓度的比较[J].癌症,2005,24(4):494-497. 被引量:8
  • 2刘炜,陈建海,任非,郭云波,阎玺庆,刘焰东.丝裂霉素C聚氰基丙烯酸正丁酯磁性纳米球血药浓度的测定[J].第一军医大学学报,2005,25(4):413-415. 被引量:2
  • 3Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100 313 patients diagnosed from 1985-1995,using the national cancer database. J Am Coll Surg,1999,189:1-7.
  • 4Kayahara M, Nagakawa T, Kobayashi H, et al. Lymphatic flow in carcinoma of the head of the pancreas. Cancer,1992,70:2061-2066.
  • 5Nagakawa T, Kobayashi H, Ueno K,et al. Clinical study of lymphtic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas. Cancer,1994,73:1155-1162.
  • 6Ishikawa O, Ohigashi H, Sasaki Y, et al. Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomy. Surgery, 1997,121:244-249.
  • 7Deki H, Sato T. An anatomic study of the peripancreatic lymphatics. Surg Radiol Anat, 1988,10:121-135.
  • 8Nagakawa T, Kobayashi H, Ueno K, et al. The pattern of lymph node involvement in carcinoma of the head of the pancreas. Int J Pancreatol, 1993,13:15-22.
  • 9Kagahara M, Nagakawa T, Ohta T, et al. Analysis of paraaortic lymph node involvement in pancreatic carcinoma. Cancer, 1999,85:583-590.
  • 10Furukawa H, Okada S, Saisho H, et al. Clincopathological features of small pancreatic adenocarcinoma. Cancer, 1996,78:986-990.

共引文献71

同被引文献26

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部